drugs

Syndicate content

Drug combination slows progression of treatment resistant bone marrow cancer

Combining a newly formulated drug with one that is already a standard treatment slows the progression of multiple myeloma, an advanced cancer of the bone marrow cells, according to a clinical trial led by a University of North Carolina at Chapel Hill School of Medicine researcher.

Read the full story

Individualizing Treatment for Multiple Myeloma Patients

Researchers at Mayo Clinic Cancer Center, in cooperation with industry partners, have, for the first time, identified tumor specific alterations in the cellular pathway by which the multiple myeloma drug bortezomib (Velcade) works, and they have identified nine new genetic mutations in cancer cells that should increase a patient's chance of responding to the agent.

Read the full story

Statin users risk heart attacks by dropping treatment or taking low doses

Doctors must emphasise importance of complying with treatment say researchers

Read the full story

Melts in your body, not in your hand

Super-stable glass may aid drug delivery through the body

Read the full story

Unusually stable glasses may benefit drugs, coatings

Just spray and chill. That sums up a new approach to making remarkably stable glassy materials from organic (carbon-containing) molecules that could lead to novel coatings and to improvements in drug delivery.

Read the full story

Bioprospecting not biopiracy

By training professionals in high-biodiversity regions to advance the drug discovery process in-country, a novel program drives drug discovery costs down as it promotes tropical biodiversity conservation. An international team describes a successful test of the program in Panama in the December, 2006 issue of BioScience.

Read the full story

solitary drug, alcohol and cigarette use puts adolescents at higher risk

Adolescents who use alcohol, cigarettes and marijuana while alone are more likely to have health and behavioral problems as young adults than their peers who consume the substances only in social settings, according to a RAND Corporation study issued today.

Read the full story

Gleevec's excellent survival rate

In five years Gleevec, the little yellow pill, has proved itself to be a miracle drug for most patients who take it.

Read the full story